Profile
Robert W.
Baldridge has been a Director of GTC Biotherapeutics, Inc. since 1994.
He provided consulting services to GTC Biotherapeutics from October 1994 to October 2000.
He has been an Independent Business Consultant since June 1988.
Mr. Baldridge was Chief Executive Officer and Chairman of TSI Corp.
from 1993 to 1994.
Former positions of Robert W. Baldridge
Companies | Position | End |
---|---|---|
REVO BIOLOGICS INC | Director/Board Member | 2009-09-30 |
TSI Corp | Chairman | 1993-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
TSI Corp | Commercial Services |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
- Stock Market
- Insiders
- Robert W. Baldridge